AVNC Insider Trading Activity and SEC Form 4 Filings
AVNC insider trading summary
No open-market insider purchases or sales of Advancis Pharmaceutical Corp (AVNC) have been reported on SEC Form 4 in the past 12 months.
Latest AVNC insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Apr 12, 2007 | Harold R Werner | Director | Buy | $2.1M (900,000 @ $2.36) |
| Apr 12, 2007 | Eric Aguiar | 10% Owner | Buy | $1.6M (682,903 @ $2.36) |
| Apr 12, 2007 | James H Cavanaugh | Director | Buy | $1.6M (682,903 @ $2.36) |
| Apr 12, 2007 | William W Crouse | 10% Owner | Buy | $1.6M (682,903 @ $2.36) |
| Apr 12, 2007 | Christopher Mirabelli | 10% Owner | Buy | $1.6M (682,903 @ $2.36) |
| Apr 12, 2007 | Augustine Lawlor | 10% Owner | Buy | $1.6M (682,903 @ $2.36) |
| Apr 12, 2007 | Healthcare Ventures Vi LP | 10% Owner | Buy | $1.6M (682,903 @ $2.36) |
| Apr 12, 2007 | Healthcare Partners Vi LP | 10% Owner | Buy | $1.6M (682,903 @ $2.36) |
| Apr 12, 2007 | John W Littlechild | 10% Owner | Buy | $1.6M (682,903 @ $2.36) |
| Apr 12, 2007 | Harold R Werner | Director | Buy | $1.6M (682,903 @ $2.36) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.